Drug intelligence / Profile preview

native cat epithelium allergen extract

Development stage
Unknown
Lead developer
Leti
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual, Percutaneous
01

Overview

Native cat epithelium allergen extract is a biological allergen extract developed by Laboratorios LETI, S.L.U. for the treatment and diagnosis of cat-related allergies. It is produced by extracting naturally occurring proteins from cat dander into a phosphate-buffered saline solution, maintaining the allergens in their unmodified (native) state. The extract contains key IgE-binding proteins such as Fel d 1, Fel d 2, Fel d 3, Fel d 4, and Fel d 7. It is primarily used in allergen-specific immunotherapy (AIT) to induce immune tolerance in individuals with allergic rhinitis or allergic asthma triggered by cat epithelium. In clinical research, it has served as a reference standard to evaluate the biological potency of modified extracts, such as depigmented or polymerized allergoids, using dose-response skin prick testing.

Brand names
AlbayAllergovitNovo-Helisen Depot
Other names
cat epithelium allergen extractnative cat extract
02

Targets

NeuraminidaseCat allergen-specific immunoglobulin E (Cat sIgE)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on native cat epithelium allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on native cat epithelium allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call